APA (7th ed.) Citation

Volpes, R., Burra, P., Germani, G., Manini, M. A., Caccamo, L., Strignano, P., . . . Nicolucci, A. (2020). Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: Effect on quality of life after liver transplantation. Health & Quality of Life Outcomes, 18(1), 1. https://doi.org/10.1186/s12955-020-01349-5

Chicago Style (17th ed.) Citation

Volpes, Riccardo, et al. "Switch from Intravenous or Intramuscular to Subcutaneous Hepatitis B Immunoglobulin: Effect on Quality of Life After Liver Transplantation." Health & Quality of Life Outcomes 18, no. 1 (2020): 1. https://doi.org/10.1186/s12955-020-01349-5.

MLA (9th ed.) Citation

Volpes, Riccardo, et al. "Switch from Intravenous or Intramuscular to Subcutaneous Hepatitis B Immunoglobulin: Effect on Quality of Life After Liver Transplantation." Health & Quality of Life Outcomes, vol. 18, no. 1, 2020, p. 1, https://doi.org/10.1186/s12955-020-01349-5.